Search results
Council Bluffs man becomes pioneer in new treatment against diabetes
Southwest Iowa's daily newspaper· 4 days agoCouncil Bluffs is taking a lead role in the fight against diabetes. A local resident recently became...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 3 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the US, regardless of ...
Valleant Releases New Article on Managing Diabetes Type 1
Digital Journal· 1 day agoOne of the most important piece of information the article tries to convey and communicate is that the cornerstone of treatment for diabetes type 1 is insulin therapy, as individuals with < ...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 4 days agoA patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo Nordisk...
37 MetroWest high school athletes to watch at the MIAA track & field state championships
The Metrowest Daily News via Yahoo Sports· 2 days agoLOGAN SULLIVAN, Hopkinton He has cleared 6-foot-4 to earn the Division 2 boys high jump top seed....
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
Motley Fool via Yahoo Finance· 2 days agoAccording to some estimates, 31% of diabetes patients use insulin therapy, either by itself or with...
Safety risk cited for Novo Nordisk's long-acting insulin
Axios· 2 days agoA long-acting insulin from Novo Nordisk was shown to have a greater risk of excessively lowering...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
NBC Washington· 4 days agoThe rivalry between Eli Lilly and Novo Nordisk extends beyond a buzzy class of weight loss and...
Thinking About Trying Mounjaro? Here's What You Can Expect Week by Week
Parade· 2 days agoObesity specialists give realistic expectations of what to expect on a typical Mounjaro journey....
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 3 days agoOf particular interest is the CTX211 program for type 1 diabetes, which is currently in phase 1 trials. CTX211 aims to treat or perhaps ...